不同神经网络预测可卡因与大麻治疗结局
本研究采用连接组预测建模(CPM)识别可卡因和大麻戒断的神经预测网络。研究1在43名接受认知行为治疗的SUD患者中重复验证可卡因网络,并测试其对大麻戒断的预测能力;研究2在33名大麻使用障碍患者中识别独立的大麻戒断网络。结果显示可卡因网络可重复预测可卡因戒断但不泛化至大麻,而大麻戒断网络在解剖上独立且对治疗应答者网络强度显著更强。
要点
- 可卡因网络在独立样本中重复验证预测可卡因戒断,但不预测大麻戒断。
- 识别出解剖独立的大麻戒断网络,特异预测大麻戒断。
- 治疗应答者大麻网络强度显著强于对照参与者。
核心结论
- 神经预测因子对成瘾物质具有特异性,可卡因与大麻戒断由不同神经网络预测。
- 大麻戒断网络为成功大麻治疗提供了新的神经机制靶点。
研究设计与样本
- 研究1:43名来自SUD认知行为治疗试验的参与者,测试可卡因网络预测能力并评估其预测大麻戒断的能力。
- 研究2:应用CPM在33名大麻使用障碍患者中识别独立大麻戒断网络。
- 额外样本:53名可卡因与阿片类共病患者和38名对照者,用于评估物质特异性和网络强度。
- 所有参与者均在治疗前后接受fMRI扫描。
主要发现
- 可卡因网络第二次外部重复验证预测未来可卡因戒断,但不泛化至大麻戒断。
- 新识别的大麻戒断网络在解剖上独立于可卡因网络,且特异预测大麻戒断。
- 治疗应答者的大麻戒断网络强度显著强于对照参与者。
临床怎么用
- 神经影像标志物可能辅助个体化治疗匹配,但尚需进一步临床验证。
- 大麻戒断网络节点可作为未来治疗干预的潜在靶点。
局限性
- 样本量较小(研究1 n=43,研究2 n=33),结果需更大样本验证。
- 研究未报告网络预测的效应量、置信区间或统计阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Treatment outcomes for individuals with substance use disorders (SUDs) are variable and more individualized approaches may be needed. Cross-validated, machine-learning methods are well-suited for probing neural mechanisms of treatment outcomes. Our prior work applied one such approach, connectome-based predictive modeling (CPM), to identify dissociable and substance-specific neural networks of cocaine and opioid abstinence. In Study 1, we aimed to replicate and extend prior work by testing the predictive ability of the cocaine network in an independent sample of 43 participants from a trial of cognitive-behavioral therapy for SUD, and evaluating its ability to predict cannabis abstinence. In Study 2, CPM was applied to identify an independent cannabis abstinence network. Additional participants were identified for a combined sample of 33 with cannabis-use disorder. Participants underwent fMRI scanning before and after treatment. Additional samples of 53 individuals with co-occurring cocaine and opioid-use disorders and 38 comparison subjects were used to assess substance specificity and network strength relative to participants without SUDs. Results demonstrated a second external replication of the cocaine network predicting future cocaine abstinence, however it did not generalize to cannabis abstinence. An independent CPM identified a novel cannabis abstinence network, which was (i) anatomically distinct from the cocaine network, (ii) specific for predicting cannabis abstinence, and for which (iii) network strength was significantly stronger in treatment responders relative to control particpants. Results provide further evidence for substance specificity of neural predictors of abstinence and provide insight into neural mechanisms of successful cannabis treatment, thereby identifying novel treatment targets. Clinical trials registation: "Computer-based training in cognitive-behavioral therapy web-based (Man VS Machine)", registration number: NCT01442597 . "Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management", registration number: NCT00350649 . "Computer-Based Training in Cognitive Behavior Therapy (CBT4CBT)", registration number: NCT01406899 .
引用
- Lichenstein SD, Kohler R, Ye F, et al. Distinct neural networks predict cocaine versus cannabis treatment outcomes. Mol Psychiatry. 2023. PMID: 37308679. doi:10.1038/s41380-023-02120-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。